English

GoodRx Financial Results for April-June 2021

English

Have you ever heard of GoodRx (ticker symbol: GDRX), a U.S. stock?

It is a company that operates a price comparison app for prescription drugs.

In this article, I will introduce the company’s financial results for the period April to June 2021, which were announced on August 11, 2021.

Financial Results for April to June 2021

EPS is 8¢ vs. 1¢ expected.

Net sales were $177 million, compared to the forecast of $175 million.

Sales growth was +43.2% YoY.

Net income was $31.1 million. Net income was $31.1 million, compared to $27.3 million in the same period last year.

Subscription sales were $14.3 million. Subscription sales were $14.3 million, compared to $6.4 million in the same period last year.

Other sales were $17.4 million. Other sales were $17.4 million, compared to $7.4 million in the same period last year.

Operating cash flow was $34.9 million. Cash flow from operations was $34.9 million, compared to $38.2 million in the same period last year.

タイトルとURLをコピーしました